Breaking

Bearish Divergence Suggests Caution For S&P 500
3 S&P 500 Charts That Point to the Next Big Move
Joe Rabil’s Undercut & Rally Pattern: From DROP to POP
The Secret To Streamlining Your Charting Workflow
Feeling Unsure About the Stock Market’s Next Move? These Charts Can Help
Senate hearing on who was ‘really running’ Biden White House kicks off Wednesday
Iran warns US joining conflict would mean ‘all-out war,’ refuses demands to give up disputed nuclear program
In Iran’s ‘forever war’ against the US, regime has targeted and killed Americans worldwide

Home
Features
- View All On Demos
Buy Now
Search for:

Investing

Lantheus increases shareholding in RAD with A$8m placement

January 10, 2025

Share on Facebook Share on Twitter Pinterest LinkedIn Tumblr Email

Share

Share on Facebook Share on Twitter Pinterest Email

Radiopharm Theranostics (RAD:AU) has announced Lantheus increases shareholding in RAD with A$8m placement

Download the PDF here.

This post appeared first on investingnews.com

0

admin

Website

Related Posts

Gold Price, Equities Flat as Fed Leaves Rates Unchanged

Graphite Processing Expansion Opportunities

10 Silver ETFs for Every Investing Style in 2025

Sign up for our newsletter to receive the latest insights, updates, and exclusive content straight to your inbox! Whether it's industry news, expert advice, or inspiring stories, we bring you valuable information that you won't find anywhere else. Stay connected with us!

Your name

Your email

By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.
Categories
- Business (411)
- Investing (1,334)
- Politics (1,628)
- Stocks (562)

Disclaimer: 2morrowgrowth.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.
Latest

Copyright © 2025 2morrowgrowth.com | All Rights Reserved

Top

Type above and press Enter to search. Press Esc to cancel.